Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study-Reference-Cited by-同舟云学术

Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study

Published:2023-06-09 Issue:7 Volume:40 Page:
ISSN:1559-131X
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Xu Manyi,Hao Yue,Zhou Huan,shi Zheng,Si Jinfei,Song Zhengbo^ORCID

Funder

the Medical Scientific Research Foundation of Zhejiang Province

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-023-02059-w.pdf

Reference22 articles.

1. Chang JC, Offin M, Falcon C, Brown D, Houck-Loomis BR, Meng F, Rudneva VA, Won HH, Amir S, Montecalvo J, Desmeules P, Kadota K, Adusumilli PS, Rusch VW, Teed S, Sabari JK, Benayed R, Nafa K, Borsu L, Li BT, Schram AM, Arcila ME, Travis WD, Ladanyi M, Drilon A, Rekhtman N. Comprehensive molecular and clinicopathologic analysis of 200 pulmonary invasive mucinous adenocarcinomas identifies distinct characteristics of molecular subtypes. Clin Cancer Res. 2021;27(14):4066–76. https://doi.org/10.1158/1078-0432.CCR-21-0423.

2. Gow CH, Hsieh MS, Liu YN, Lee YH, Shih JY. Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma. Cancers. 2021;13(16):4103. https://doi.org/10.3390/cancers13164103.

3. Cai D, Li H, Wang R, Li Y, Pan Y, Hu H, Zhang Y, Gong R, Pan B, Sun Y, Chen H. Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma. Onco Targets Ther. 2014;7:2127–32. https://doi.org/10.2147/OTT.S70984.

4. Yang SR, Chang JC, Leduc C, Tan KS, Dogan S, Benayed R, Borsu L, Offin M, Drilon A, Travis WD, Arcila ME, Ladanyi M, Rekhtman N. Invasive mucinous adenocarcinomas with spatially separate lung lesions: analysis of clonal relationship by comparative molecular profiling. J Thorac Oncol. 2021;16(7):1188–99. https://doi.org/10.1016/j.jtho.2021.03.023.

5. Luo J, Wang R, Han B, Zhang J, Zhao H, Fang W, Luo Q, Yang J, Yang Y, Zhu L, Chen T, Cheng X, Huang Q, Wang Y, Zheng J, Chen H. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma. J Cancer Res Clin Oncol. 2016;142(8):1837–45. https://doi.org/10.1007/s00432-016-2201-9.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of local ablative therapy in patients with advanced invasive mucinous adenocarcinoma of the lung;Journal of Cancer Research and Clinical Oncology;2024-09-04

2. Pulmonary mucinous adenocarcinoma: An overview of pathophysiology and advancements in treatment;Heliyon;2024-05

3. Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancreatic Cancer;Journal of Proteome Research;2024-02-02